Related Experiment Video
Updated: Jul 13, 2026

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
Published on: February 8, 2022
Migraine and percutaneous patent foramen ovale closure: a systematic review and meta-analysis
Yu-Jie Shi1, Jun Lv2, Xing-Ting Han3
1Department of Neurology, Xi'an Jiaotong University, Xi'an, China.
Background:
The association between patent foramen ovale (PFO) and migraine with aura (MA) is well established. However, the benefits of PFO closure are less certain in patients with migraine without aura (MwoA).
Methods:
We systematically searched Pubmed for pertinent clinical studies published from January 2000 to July 2015. The primary end-point was the elimination or significant improvement of migraine symptoms after PFO closure.
Results:
Upon screening an initial list of 315 publications, we identified eight studies that included 546 patients. Overall, our analysis indicated a significant improvement of migraine in 81% of MA cases compared to only 63% of MwoA cases. The summary odds ratio was 2.5 (95% confidence interval 1.09-5.73), and the benefits of PFO closure were significantly greater for patients with MA compared to patients with MwoA (P = 0.03).
Conclusions:
The presence of aura provides a reference standard for the clinical selection of patients with migraine for PFO closure intervention.
Insights
Patent foramen ovale (PFO) closure significantly improves migraine with aura (MA). Benefits are less certain for migraine without aura (MwoA), suggesting aura presence guides PFO closure decisions.
Area of Science:
- Cardiology
- Neurology
- Medical Devices
Background:
- Established association between patent foramen ovale (PFO) and migraine with aura (MA).
- Uncertainty regarding PFO closure benefits for migraine without aura (MwoA).
Purpose of the Study:
- To systematically evaluate the efficacy of PFO closure in patients experiencing migraine.
- To compare the outcomes of PFO closure for migraine with aura versus migraine without aura.
Main Methods:
- Systematic literature search of Pubmed (January 2000 - July 2015).
- Inclusion of eight clinical studies comprising 546 patients.
- Primary endpoint: elimination or significant improvement of migraine symptoms post-PFO closure.
Main Results:
- Significant migraine improvement in 81% of MA cases versus 63% of MwoA cases after PFO closure.
- Summary odds ratio of 2.5 (95% CI 1.09-5.73) for migraine improvement.
- PFO closure benefits were significantly greater in MA patients compared to MwoA patients (P=0.03).
Conclusions:
- The presence of aura is a key factor in selecting migraine patients for PFO closure.
- PFO closure demonstrates greater efficacy in patients with migraine with aura.
- Aura presence serves as a clinical reference standard for PFO closure interventions in migraine patients.
Related Concept Videos
Angle Closure Glaucoma: Treatment
Increased Intracranial Pressure ll: Pathophysiology

